Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Randomized Controlled Experimental Endotoxemia Study on the Effects of the Cytokine-adsorber CytoSorb on the Development of Immunoparalysis in Humans

NCT04643639 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04643639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04643639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Randomized Controlled Experimental Endotoxemia Study on the Effects of the Cytokine-adsorber CytoSorb on the Development of Immunoparalysis in Humans
Lead sponsor
Radboud University Medical Center
Phase
Phase 3
Overall status
Completed
Start date
September 16, 2020
Completion date
October 19, 2022
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood purification, hemoperfusion, immune deficiency, sepsis